nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—Etomidate—SLC2A1—peripheral nervous system neoplasm	0.02	0.845	CrCbGaD
Pseudoephedrine—Ephedrine—BCHE—peripheral nervous system neoplasm	0.00285	0.12	CrCbGaD
Pseudoephedrine—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.00263	0.00585	CcSEcCtD
Pseudoephedrine—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.00261	0.00579	CcSEcCtD
Pseudoephedrine—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.00261	0.00579	CcSEcCtD
Pseudoephedrine—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.00234	0.0052	CcSEcCtD
Pseudoephedrine—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.0052	CcSEcCtD
Pseudoephedrine—Irritability—Cisplatin—peripheral nervous system neoplasm	0.00234	0.00519	CcSEcCtD
Pseudoephedrine—Dysuria—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00516	CcSEcCtD
Pseudoephedrine—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00231	0.00513	CcSEcCtD
Pseudoephedrine—Tension—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00497	CcSEcCtD
Pseudoephedrine—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00224	0.00497	CcSEcCtD
Pseudoephedrine—Dysuria—Vincristine—peripheral nervous system neoplasm	0.00224	0.00497	CcSEcCtD
Pseudoephedrine—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00222	0.00492	CcSEcCtD
Pseudoephedrine—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00222	0.00492	CcSEcCtD
Pseudoephedrine—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00221	0.00491	CcSEcCtD
Pseudoephedrine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00214	0.00475	CcSEcCtD
Pseudoephedrine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00214	0.00475	CcSEcCtD
Pseudoephedrine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00471	CcSEcCtD
Pseudoephedrine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.00466	CcSEcCtD
Pseudoephedrine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.0021	0.00466	CcSEcCtD
Pseudoephedrine—Sweating—Vincristine—peripheral nervous system neoplasm	0.00204	0.00454	CcSEcCtD
Pseudoephedrine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00448	CcSEcCtD
Pseudoephedrine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00448	CcSEcCtD
Pseudoephedrine—Delirium—Epirubicin—peripheral nervous system neoplasm	0.00201	0.00447	CcSEcCtD
Pseudoephedrine—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00439	CcSEcCtD
Pseudoephedrine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00197	0.00438	CcSEcCtD
Pseudoephedrine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00197	0.00438	CcSEcCtD
Pseudoephedrine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00196	0.00435	CcSEcCtD
Pseudoephedrine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00194	0.00432	CcSEcCtD
Pseudoephedrine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00194	0.00432	CcSEcCtD
Pseudoephedrine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00194	0.0043	CcSEcCtD
Pseudoephedrine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00194	0.0043	CcSEcCtD
Pseudoephedrine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00192	0.00426	CcSEcCtD
Pseudoephedrine—Hallucination—Vincristine—peripheral nervous system neoplasm	0.0019	0.00423	CcSEcCtD
Pseudoephedrine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00188	0.00417	CcSEcCtD
Pseudoephedrine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00188	0.00417	CcSEcCtD
Pseudoephedrine—Delirium—Doxorubicin—peripheral nervous system neoplasm	0.00186	0.00414	CcSEcCtD
Pseudoephedrine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00404	CcSEcCtD
Pseudoephedrine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00404	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00181	0.00403	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.0018	0.004	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.0018	0.004	CcSEcCtD
Pseudoephedrine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00179	0.00399	CcSEcCtD
Pseudoephedrine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00179	0.00398	CcSEcCtD
Pseudoephedrine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00178	0.00394	CcSEcCtD
Pseudoephedrine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00178	0.00394	CcSEcCtD
Pseudoephedrine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00177	0.00394	CcSEcCtD
Pseudoephedrine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00175	0.00389	CcSEcCtD
Pseudoephedrine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00172	0.00383	CcSEcCtD
Pseudoephedrine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00377	CcSEcCtD
Pseudoephedrine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00168	0.00374	CcSEcCtD
Pseudoephedrine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.00374	CcSEcCtD
Pseudoephedrine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00373	CcSEcCtD
Pseudoephedrine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00167	0.00372	CcSEcCtD
Pseudoephedrine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00369	CcSEcCtD
Pseudoephedrine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00369	CcSEcCtD
Pseudoephedrine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00165	0.00367	CcSEcCtD
Pseudoephedrine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00164	0.00364	CcSEcCtD
Pseudoephedrine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00164	0.00364	CcSEcCtD
Pseudoephedrine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00164	0.00364	CcSEcCtD
Pseudoephedrine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00163	0.00363	CcSEcCtD
Pseudoephedrine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.0036	CcSEcCtD
Pseudoephedrine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00162	0.0036	CcSEcCtD
Pseudoephedrine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.0036	CcSEcCtD
Pseudoephedrine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00162	0.00359	CcSEcCtD
Pseudoephedrine—Pain—Topotecan—peripheral nervous system neoplasm	0.00161	0.00357	CcSEcCtD
Pseudoephedrine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.0016	0.00355	CcSEcCtD
Pseudoephedrine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00159	0.00354	CcSEcCtD
Pseudoephedrine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00159	0.00354	CcSEcCtD
Pseudoephedrine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00353	CcSEcCtD
Pseudoephedrine—Pain—Melphalan—peripheral nervous system neoplasm	0.00157	0.00349	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00155	0.00344	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00341	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00341	CcSEcCtD
Pseudoephedrine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00153	0.0034	CcSEcCtD
Pseudoephedrine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00339	CcSEcCtD
Pseudoephedrine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00151	0.00336	CcSEcCtD
Pseudoephedrine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.0015	0.00333	CcSEcCtD
Pseudoephedrine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.00332	CcSEcCtD
Pseudoephedrine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00148	0.0033	CcSEcCtD
Pseudoephedrine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00327	CcSEcCtD
Pseudoephedrine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00147	0.00327	CcSEcCtD
Pseudoephedrine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00147	0.00327	CcSEcCtD
Pseudoephedrine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00326	CcSEcCtD
Pseudoephedrine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00145	0.00322	CcSEcCtD
Pseudoephedrine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00144	0.0032	CcSEcCtD
Pseudoephedrine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00316	CcSEcCtD
Pseudoephedrine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00142	0.00315	CcSEcCtD
Pseudoephedrine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00138	0.00307	CcSEcCtD
Pseudoephedrine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00306	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00303	CcSEcCtD
Pseudoephedrine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00135	0.00299	CcSEcCtD
Pseudoephedrine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00299	CcSEcCtD
Pseudoephedrine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00297	CcSEcCtD
Pseudoephedrine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00297	CcSEcCtD
Pseudoephedrine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00132	0.00294	CcSEcCtD
Pseudoephedrine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00132	0.00293	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00131	0.00292	CcSEcCtD
Pseudoephedrine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.0013	0.00289	CcSEcCtD
Pseudoephedrine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.0013	0.00288	CcSEcCtD
Pseudoephedrine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.0013	0.00288	CcSEcCtD
Pseudoephedrine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00284	CcSEcCtD
Pseudoephedrine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.0028	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.00279	CcSEcCtD
Pseudoephedrine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00278	CcSEcCtD
Pseudoephedrine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00276	CcSEcCtD
Pseudoephedrine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00124	0.00276	CcSEcCtD
Pseudoephedrine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00123	0.00274	CcSEcCtD
Pseudoephedrine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00123	0.00274	CcSEcCtD
Pseudoephedrine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00123	0.00273	CcSEcCtD
Pseudoephedrine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00273	CcSEcCtD
Pseudoephedrine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00121	0.00269	CcSEcCtD
Pseudoephedrine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00268	CcSEcCtD
Pseudoephedrine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.0012	0.00267	CcSEcCtD
Pseudoephedrine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00119	0.00265	CcSEcCtD
Pseudoephedrine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00263	CcSEcCtD
Pseudoephedrine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00263	CcSEcCtD
Pseudoephedrine—Rash—Topotecan—peripheral nervous system neoplasm	0.00118	0.00263	CcSEcCtD
Pseudoephedrine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00118	0.00263	CcSEcCtD
Pseudoephedrine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00118	0.00263	CcSEcCtD
Pseudoephedrine—Headache—Topotecan—peripheral nervous system neoplasm	0.00118	0.00261	CcSEcCtD
Pseudoephedrine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00261	CcSEcCtD
Pseudoephedrine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00261	CcSEcCtD
Pseudoephedrine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00261	CcSEcCtD
Pseudoephedrine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00261	CcSEcCtD
Pseudoephedrine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00261	CcSEcCtD
Pseudoephedrine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00117	0.0026	CcSEcCtD
Pseudoephedrine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00259	CcSEcCtD
Pseudoephedrine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00259	CcSEcCtD
Pseudoephedrine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00117	0.00259	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00258	CcSEcCtD
Pseudoephedrine—Pain—Vincristine—peripheral nervous system neoplasm	0.00116	0.00258	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00258	CcSEcCtD
Pseudoephedrine—Rash—Melphalan—peripheral nervous system neoplasm	0.00116	0.00257	CcSEcCtD
Pseudoephedrine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00116	0.00257	CcSEcCtD
Pseudoephedrine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00115	0.00255	CcSEcCtD
Pseudoephedrine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00255	CcSEcCtD
Pseudoephedrine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00248	CcSEcCtD
Pseudoephedrine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00112	0.00248	CcSEcCtD
Pseudoephedrine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00111	0.00247	CcSEcCtD
Pseudoephedrine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00246	CcSEcCtD
Pseudoephedrine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00246	CcSEcCtD
Pseudoephedrine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00243	CcSEcCtD
Pseudoephedrine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00109	0.00243	CcSEcCtD
Pseudoephedrine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00108	0.00239	CcSEcCtD
Pseudoephedrine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00108	0.00239	CcSEcCtD
Pseudoephedrine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00238	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00106	0.00237	CcSEcCtD
Pseudoephedrine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00235	CcSEcCtD
Pseudoephedrine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00105	0.00233	CcSEcCtD
Pseudoephedrine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00232	CcSEcCtD
Pseudoephedrine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00228	CcSEcCtD
Pseudoephedrine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00226	CcSEcCtD
Pseudoephedrine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00225	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000991	0.0022	CcSEcCtD
Pseudoephedrine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000982	0.00218	CcSEcCtD
Pseudoephedrine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000979	0.00217	CcSEcCtD
Pseudoephedrine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000976	0.00217	CcSEcCtD
Pseudoephedrine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000968	0.00215	CcSEcCtD
Pseudoephedrine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00096	0.00213	CcSEcCtD
Pseudoephedrine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000958	0.00213	CcSEcCtD
Pseudoephedrine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000951	0.00211	CcSEcCtD
Pseudoephedrine—Pain—Etoposide—peripheral nervous system neoplasm	0.000942	0.00209	CcSEcCtD
Pseudoephedrine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00094	0.00209	CcSEcCtD
Pseudoephedrine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.00207	CcSEcCtD
Pseudoephedrine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000928	0.00206	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000908	0.00202	CcSEcCtD
Pseudoephedrine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000904	0.00201	CcSEcCtD
Pseudoephedrine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000899	0.002	CcSEcCtD
Pseudoephedrine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000897	0.00199	CcSEcCtD
Pseudoephedrine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00089	0.00198	CcSEcCtD
Pseudoephedrine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000889	0.00198	CcSEcCtD
Pseudoephedrine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000885	0.00197	CcSEcCtD
Pseudoephedrine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000884	0.00196	CcSEcCtD
Pseudoephedrine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000871	0.00193	CcSEcCtD
Pseudoephedrine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000865	0.00192	CcSEcCtD
Pseudoephedrine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000863	0.00192	CcSEcCtD
Pseudoephedrine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000859	0.00191	CcSEcCtD
Pseudoephedrine—Rash—Vincristine—peripheral nervous system neoplasm	0.000857	0.0019	CcSEcCtD
Pseudoephedrine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000857	0.0019	CcSEcCtD
Pseudoephedrine—Headache—Vincristine—peripheral nervous system neoplasm	0.000852	0.00189	CcSEcCtD
Pseudoephedrine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000838	0.00186	CcSEcCtD
Pseudoephedrine—Selegiline—ABCB1—peripheral nervous system neoplasm	0.000827	0.0349	CrCbGaD
Pseudoephedrine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000819	0.00182	CcSEcCtD
Pseudoephedrine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000808	0.00179	CcSEcCtD
Pseudoephedrine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00079	0.00176	CcSEcCtD
Pseudoephedrine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000776	0.00173	CcSEcCtD
Pseudoephedrine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000765	0.0017	CcSEcCtD
Pseudoephedrine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000758	0.00168	CcSEcCtD
Pseudoephedrine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000757	0.00168	CcSEcCtD
Pseudoephedrine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000742	0.00165	CcSEcCtD
Pseudoephedrine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000735	0.00163	CcSEcCtD
Pseudoephedrine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000728	0.00162	CcSEcCtD
Pseudoephedrine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000727	0.00162	CcSEcCtD
Pseudoephedrine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000718	0.0016	CcSEcCtD
Pseudoephedrine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000714	0.00159	CcSEcCtD
Pseudoephedrine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0007	0.00156	CcSEcCtD
Pseudoephedrine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000695	0.00154	CcSEcCtD
Pseudoephedrine—Rash—Etoposide—peripheral nervous system neoplasm	0.000695	0.00154	CcSEcCtD
Pseudoephedrine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000694	0.00154	CcSEcCtD
Pseudoephedrine—Headache—Etoposide—peripheral nervous system neoplasm	0.00069	0.00153	CcSEcCtD
Pseudoephedrine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.00153	CcSEcCtD
Pseudoephedrine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00068	0.00151	CcSEcCtD
Pseudoephedrine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00068	0.00151	CcSEcCtD
Pseudoephedrine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.0015	CcSEcCtD
Pseudoephedrine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000669	0.00149	CcSEcCtD
Pseudoephedrine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000654	0.00145	CcSEcCtD
Pseudoephedrine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000653	0.00145	CcSEcCtD
Pseudoephedrine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000644	0.00143	CcSEcCtD
Pseudoephedrine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.00143	CcSEcCtD
Pseudoephedrine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000642	0.00143	CcSEcCtD
Pseudoephedrine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.0014	CcSEcCtD
Pseudoephedrine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000623	0.00138	CcSEcCtD
Pseudoephedrine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000619	0.00137	CcSEcCtD
Pseudoephedrine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000604	0.00134	CcSEcCtD
Pseudoephedrine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000603	0.00134	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000597	0.00133	CcSEcCtD
Pseudoephedrine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.00132	CcSEcCtD
Pseudoephedrine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.00132	CcSEcCtD
Pseudoephedrine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000589	0.00131	CcSEcCtD
Pseudoephedrine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.00128	CcSEcCtD
Pseudoephedrine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000559	0.00124	CcSEcCtD
Pseudoephedrine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.00124	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.00123	CcSEcCtD
Pseudoephedrine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000551	0.00122	CcSEcCtD
Pseudoephedrine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.00121	CcSEcCtD
Pseudoephedrine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000544	0.00121	CcSEcCtD
Pseudoephedrine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000537	0.00119	CcSEcCtD
Pseudoephedrine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000528	0.00117	CcSEcCtD
Pseudoephedrine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.00115	CcSEcCtD
Pseudoephedrine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.00113	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000509	0.00113	CcSEcCtD
Pseudoephedrine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.00112	CcSEcCtD
Pseudoephedrine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.0011	CcSEcCtD
Pseudoephedrine—SLC6A3—nerve—peripheral nervous system neoplasm	0.00049	0.0946	CbGeAlD
Pseudoephedrine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.00109	CcSEcCtD
Pseudoephedrine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000488	0.00108	CcSEcCtD
Pseudoephedrine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.000484	0.0935	CbGeAlD
Pseudoephedrine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.00105	CcSEcCtD
Pseudoephedrine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.001	CcSEcCtD
Pseudoephedrine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.000444	0.0856	CbGeAlD
Pseudoephedrine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000984	CcSEcCtD
Pseudoephedrine—NFATC1—cerebellum—peripheral nervous system neoplasm	0.000429	0.0829	CbGeAlD
Pseudoephedrine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000911	CcSEcCtD
Pseudoephedrine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000907	CcSEcCtD
Pseudoephedrine—SLC6A2—nerve—peripheral nervous system neoplasm	0.000396	0.0763	CbGeAlD
Pseudoephedrine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000872	CcSEcCtD
Pseudoephedrine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000391	0.0754	CbGeAlD
Pseudoephedrine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000865	CcSEcCtD
Pseudoephedrine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000864	CcSEcCtD
Pseudoephedrine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000859	CcSEcCtD
Pseudoephedrine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000839	CcSEcCtD
Pseudoephedrine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000815	CcSEcCtD
Pseudoephedrine—MAOA—nerve—peripheral nervous system neoplasm	0.000365	0.0703	CbGeAlD
Pseudoephedrine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000807	CcSEcCtD
Pseudoephedrine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.0008	CcSEcCtD
Pseudoephedrine—MAOA—ganglion—peripheral nervous system neoplasm	0.00036	0.0695	CbGeAlD
Pseudoephedrine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.0008	CcSEcCtD
Pseudoephedrine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000795	CcSEcCtD
Pseudoephedrine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000754	CcSEcCtD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000271	0.000519	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000268	0.000515	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000268	0.000515	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	0.000267	0.000513	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000267	0.000512	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000267	0.000512	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTPN11—peripheral nervous system neoplasm	0.000266	0.000511	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000265	0.000509	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000263	0.000504	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000263	0.000504	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000259	0.000498	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000256	0.000491	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000255	0.000489	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000254	0.000487	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000251	0.000482	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00025	0.00048	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000248	0.000476	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000247	0.000474	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—PTPN11—peripheral nervous system neoplasm	0.000244	0.000468	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GNS—peripheral nervous system neoplasm	0.000244	0.000468	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000242	0.000464	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000238	0.000456	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000236	0.000453	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000235	0.000451	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000234	0.000449	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000234	0.000449	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NME1—peripheral nervous system neoplasm	0.000234	0.000448	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000232	0.000446	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00023	0.000442	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00023	0.000441	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ERBB2—peripheral nervous system neoplasm	0.000228	0.000437	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000227	0.000436	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000227	0.000435	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	0.000226	0.000433	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000225	0.000432	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—COX2—peripheral nervous system neoplasm	0.000225	0.000432	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000221	0.000424	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000218	0.000418	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000217	0.000417	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000217	0.000417	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000214	0.000412	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000214	0.000412	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—peripheral nervous system neoplasm	0.000214	0.00041	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000211	0.000405	CbGpPWpGaD
Pseudoephedrine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.000211	0.0406	CbGeAlD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00021	0.000404	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB2—peripheral nervous system neoplasm	0.00021	0.000404	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00021	0.000403	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000207	0.000397	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—peripheral nervous system neoplasm	0.000205	0.000393	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000204	0.000392	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000202	0.000387	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000195	0.000374	CbGpPWpGaD
Pseudoephedrine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000193	0.0372	CbGeAlD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000193	0.00037	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB2—peripheral nervous system neoplasm	0.000193	0.00037	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000192	0.000369	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000192	0.000369	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000192	0.000369	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MET—peripheral nervous system neoplasm	0.000191	0.000366	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00019	0.000365	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00019	0.000365	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000189	0.000363	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000188	0.000361	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000186	0.000358	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000186	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000181	0.000348	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000181	0.000347	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00018	0.000346	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000177	0.00034	CbGpPWpGaD
Pseudoephedrine—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.000177	0.0341	CbGeAlD
Pseudoephedrine—ADRA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000176	0.000339	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000176	0.000338	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000175	0.000335	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000174	0.000333	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000173	0.000333	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000173	0.000333	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NRAS—peripheral nervous system neoplasm	0.000173	0.000333	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000173	0.000332	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00017	0.000326	CbGpPWpGaD
Pseudoephedrine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00017	0.0328	CbGeAlD
Pseudoephedrine—MAOA—parotid gland—peripheral nervous system neoplasm	0.000167	0.0322	CbGeAlD
Pseudoephedrine—ADRA2A—Metabolism—GNS—peripheral nervous system neoplasm	0.000163	0.000313	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000162	0.000312	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000161	0.000309	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00016	0.000308	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NRAS—peripheral nervous system neoplasm	0.00016	0.000307	CbGpPWpGaD
Pseudoephedrine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000158	0.0305	CbGeAlD
Pseudoephedrine—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000158	0.000303	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000158	0.000302	CbGpPWpGaD
Pseudoephedrine—MAOA—brainstem—peripheral nervous system neoplasm	0.000156	0.0302	CbGeAlD
Pseudoephedrine—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	0.000156	0.0003	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000152	0.000291	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000152	0.000291	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	0.00015	0.000289	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	0.00015	0.000288	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MYC—peripheral nervous system neoplasm	0.000149	0.000286	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000148	0.000285	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000148	0.000283	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000147	0.000283	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000147	0.000282	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NRAS—peripheral nervous system neoplasm	0.000147	0.000281	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000147	0.000281	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000146	0.000281	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000141	0.000271	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000141	0.00027	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00014	0.00027	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000139	0.000267	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000138	0.000264	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000137	0.000263	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000136	0.000261	CbGpPWpGaD
Pseudoephedrine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000136	0.0262	CbGeAlD
Pseudoephedrine—ADRB2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000135	0.000259	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000134	0.000258	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000134	0.000257	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000133	0.000255	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000131	0.000251	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00013	0.000249	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—peripheral nervous system neoplasm	0.000127	0.000243	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000127	0.000243	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000125	0.000239	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000125	0.000239	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000124	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000123	0.000236	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00012	0.000231	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000119	0.000228	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000118	0.000226	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000117	0.000225	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TH—peripheral nervous system neoplasm	0.000117	0.000225	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—peripheral nervous system neoplasm	0.000117	0.000225	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000116	0.000223	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000114	0.000219	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000114	0.000219	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000113	0.000217	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000112	0.000215	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—peripheral nervous system neoplasm	0.000112	0.000215	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000111	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000111	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.00011	0.00021	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000108	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000107	0.000206	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—peripheral nervous system neoplasm	0.000107	0.000206	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	0.000106	0.000204	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000106	0.000203	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000104	0.0002	CbGpPWpGaD
Pseudoephedrine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000104	0.02	CbGeAlD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000104	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000104	0.000199	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—peripheral nervous system neoplasm	0.000103	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000103	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000103	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000102	0.000197	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	0.000102	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.97e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	9.86e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	9.79e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.75e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GNAS—peripheral nervous system neoplasm	9.58e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.52e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.51e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.48e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—peripheral nervous system neoplasm	9.47e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ABCB1—peripheral nervous system neoplasm	9.4e-05	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.31e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—CYP2D6—brainstem—peripheral nervous system neoplasm	9.3e-05	0.0179	CbGeAlD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.06e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.83e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.57e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.37e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	8.34e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	8.26e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.2e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.19e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.14e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.96e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.95e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	7.84e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—ADRA1A—cerebellum—peripheral nervous system neoplasm	7.78e-05	0.015	CbGeAlD
Pseudoephedrine—TNF—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.76e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.76e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—MAOA—cerebellum—peripheral nervous system neoplasm	7.71e-05	0.0149	CbGeAlD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.7e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.59e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.25e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.24e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.15e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.12e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.96e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.93e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—peripheral nervous system neoplasm	6.85e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.77e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	6.59e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.58e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	6.43e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	6.4e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.29e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	6.28e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.27e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.12e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.12e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA2A—cerebellum—peripheral nervous system neoplasm	5.92e-05	0.0114	CbGeAlD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.83e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.76e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	5.43e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.35e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.18e-05	9.95e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.11e-05	9.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	5.04e-05	9.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.03e-05	9.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.95e-05	9.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.92e-05	9.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.84e-05	9.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	4.82e-05	9.26e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—cerebellum—peripheral nervous system neoplasm	4.58e-05	0.00885	CbGeAlD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	4.26e-05	8.18e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.17e-05	8e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.09e-05	7.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.07e-05	7.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4e-05	7.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.91e-05	7.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.82e-05	7.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.78e-05	7.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.72e-05	7.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.68e-05	7.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.6e-05	6.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.58e-05	6.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.55e-05	6.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.5e-05	6.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.47e-05	6.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.25e-05	6.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.18e-05	6.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.16e-05	6.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.98e-05	5.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.97e-05	5.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.94e-05	5.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.91e-05	5.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.9e-05	5.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.87e-05	5.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.77e-05	5.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.77e-05	5.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.71e-05	5.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.69e-05	5.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.67e-05	5.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.63e-05	5.05e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—peripheral nervous system neoplasm	2.58e-05	4.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.44e-05	4.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.41e-05	4.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.27e-05	4.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.24e-05	4.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.24e-05	4.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.22e-05	4.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.18e-05	4.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.13e-05	4.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.08e-05	4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.92e-05	3.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.88e-05	3.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.84e-05	3.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.76e-05	3.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.73e-05	3.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.71e-05	3.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.64e-05	3.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.55e-05	2.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.44e-05	2.77e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.13e-05	2.16e-05	CbGpPWpGaD
